Articles written by: Davis Scott

FibroGen Inc. (FGEN)’s Financial Results Comparing With AnaptysBio Inc. (NASDAQ:ANAB)

FibroGen Inc. (NASDAQ:FGEN) and AnaptysBio Inc. (NASDAQ:ANAB) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio FibroGen Inc. […]

Comparison of Duff & Phelps Select Energy MLP Fund Inc. (DSE) and Artisan Partners Asset Management Inc. (NYSE:APAM)

Duff & Phelps Select Energy MLP Fund Inc. (NYSE:DSE) and Artisan Partners Asset Management Inc. (NYSE:APAM) compete with each other in the Asset Management sector. We will analyze and compare their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income […]

Chardan Healthcare Acquisition Corp. (CHAC)’s Financial Results Comparing With Global Medical REIT Inc. (NYSE:GMRE)

This is therefore a comparing of the institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations in Chardan Healthcare Acquisition Corp. (NYSEAMERICAN:CHAC) and Global Medical REIT Inc. (NYSE:GMRE). The two are both Conglomerates companies that compete with one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

ACI Worldwide Inc. (ACIW) and Varonis Systems Inc. (NASDAQ:VRNS) Contrasting side by side

This is a contrast between ACI Worldwide Inc. (NASDAQ:ACIW) and Varonis Systems Inc. (NASDAQ:VRNS) based on their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. The two companies are Technical & System Software and they also compete with each other. Valuation & Earnings Gross Revenue Price/Sales Ratio Net […]

Wells Fargo Advantage Multi-Sector Income Fund (ERC)’s Financial Results Comparing With Eaton Vance New York Municipal Bond Fund (NYSE:ENX)

This is therefore a contrasting of the risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation in Wells Fargo Advantage Multi-Sector Income Fund (NYSE:ERC) and Eaton Vance New York Municipal Bond Fund (NYSE:ENX). The two are both Asset Management companies that compete with one another. Earnings and Valuation Gross […]

Pieris Pharmaceuticals Inc. (PIRS) and Scholar Rock Holding Corporation (NASDAQ:SRRK) Comparison side by side

As Biotechnology businesses, Pieris Pharmaceuticals Inc. (NASDAQ:PIRS) and Scholar Rock Holding Corporation (NASDAQ:SRRK), are affected by compare. This especially applies to their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pieris Pharmaceuticals Inc. 4 […]

BridgeBio Pharma Inc. (BBIO)’s Financial Results Comparing With Strongbridge Biopharma plc (NASDAQ:SBBP)

BridgeBio Pharma Inc. (NASDAQ:BBIO) and Strongbridge Biopharma plc (NASDAQ:SBBP), are influenced by contrast since they are both players in the Biotechnology. These factors are particularly influence the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation of the two firms. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income […]

Reata Pharmaceuticals Inc. (RETA) and Turning Point Therapeutics Inc. (NASDAQ:TPTX) Comparing side by side

Both Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Turning Point Therapeutics Inc. (NASDAQ:TPTX) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Reata Pharmaceuticals […]